Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non–Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation

BACKGROUND AND PURPOSE—: Once a patient with atrial fibrillation experiences an embolic event, the risk of a recurrent event increases 2.6-fold. New treatments have emerged as viable treatment alternatives to warfarin for stroke risk reduction in secondary prevention populations. This analysis sough...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Vivek Y., Akehurst, Ronald L., Amorosi, Stacey L., Gavaghan, Meghan B., Hertz, Deanna S., Holmes, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976225/
https://www.ncbi.nlm.nih.gov/pubmed/29739915
http://dx.doi.org/10.1161/STROKEAHA.117.018825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976225/
https://www.ncbi.nlm.nih.gov/pubmed/29739915
http://dx.doi.org/10.1161/STROKEAHA.117.018825

Ejemplares similares